Contribution of Host Immune Responses Against Influenza D Virus Infection Toward Secondary Bacterial Infection in a Mouse Model

• Published in: Viruses 2019-10, Vol.11 (11), p.994
• Main Authors: Skelton, Raegan M, Shepardson, Kelly M, Hatton, Alexis, Wilson, Patrick T, Sreenivasan, Chithra, Yu, Jieshi, Wang, Dan, Huber, Victor C, Rynda-Apple, Agnieszka
• Format: Article
• Language: English
• Subjects: A549 Cells; Animals; Coinfection - immunology; Disease Models, Animal; Female; Humans; influenza d virus; interferon; Interferon-beta - metabolism; macrophages; Mice; Mice, Inbred C57BL; Orthomyxoviridae Infections - immunology; Orthomyxoviridae Infections - virology; secondary bacterial infection; Staphylococcal Infections - immunology; Staphylococcal Infections - prevention & control; Staphylococcus aureus - immunology; Survival Analysis; Thogotovirus - immunology
• ISSN: 1999-4915; 1999-4915
• DOI: 10.3390/v11110994

Influenza D viruses (IDV) are known to co-circulate with viral and bacterial pathogens in cattle and other ruminants. Currently, there is limited knowledge regarding host responses to IDV infection and whether IDV infection affects host susceptibility to secondary bacterial infections. To begin to address this gap in knowledge, the current study utilized a combination of and approaches to evaluate host cellular responses against primary IDV infection and secondary bacterial infection with . Primary IDV infection in mice did not result in clinical signs of disease and it did not enhance the susceptibility to secondary infection. Rather, IDV infection appeared to protect mice from the usual clinical features of secondary bacterial infection, as demonstrated by improved weight loss, survival, and recovery when compared to infection alone. We found a notable increase in IFN-β expression following IDV infection while utilizing human alveolar epithelial A549 cells to analyze early anti-viral responses to IDV infection. These results demonstrate for the first time that IDV infection does not increase the susceptibility to secondary bacterial infection with , with evidence that anti-viral immune responses during IDV infection might protect the host against these potentially deadly outcomes.